KRISTA LYNN LONG

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VINITA, OK NPI 1972030682

General Payments — all program years on this page

$1,429.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $347.51 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $347.5120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $462.4930
2022 $230.7315
2023 $388.5723
2024 $347.5120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087139402 Novartis Pharmaceuticals Corporation $20.66 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100317942 Novo Nordisk Inc $19.38 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100623658 Novo Nordisk Inc $19.66 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105389724 AstraZeneca Pharmaceuticals LP $13.48 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105716330 AstraZeneca Pharmaceuticals LP $16.80 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107552591 ABBVIE INC. $16.83 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107552593 ABBVIE INC. $14.45 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107552595 ABBVIE INC. $16.59 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107552597 ABBVIE INC. $17.29 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117613543 Amgen Inc. $15.80 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131765484 PFIZER INC. $15.29 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139464304 Astellas Pharma US Inc $14.04 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141658520 Merck Sharp & Dohme LLC $17.30 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141856088 Merck Sharp & Dohme LLC $19.37 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141924452 Merck Sharp & Dohme LLC $19.67 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143535560 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.19 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146052661 Lundbeck LLC $15.13 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146052663 Lundbeck LLC $15.28 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151552878 Teva Pharmaceuticals USA, Inc. $22.02 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153372475 Dexcom, Inc. $22.28 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.